In the ever-evolving landscape of cancer therapy, immune checkpoint inhibitors have emerged as promising avenues for therapeutic antibody development. Our presentation will share GenScript's comprehensive suite of products and services tailored to empower scientists in the field of cancer therapeutic antibody development with emphasis on Immune Checkpoints. Join us as we explore how GenScript's innovative solutions, ranging from antibody generation to bioassay development, protein expression, and beyond, can accelerate your efforts in harnessing the power of immune checkpoint inhibitors to combat cancer.

Learning Objectives:

1. Explore GenScript's custom antibody generation and optimization services tailored for immune checkpoint proteins.

2. Learn about high-quality protein expression services for immune checkpoint studies.

3. Gain insights into cell line development and its role in stable expression of immune checkpoint proteins.